Structure-Activity Relationships for CYP4B1 Bioactivation of 4-Ipomeanol Congeners: Direct Correlation between Cytotoxicity and Trapped Reactive Intermediates

被引:10
|
作者
Kowalski, John P. [1 ]
McDonald, Matthew G. [1 ]
Whittington, Dale [1 ]
Guttman, Miklos [1 ]
Scian, Michele [1 ]
Girhard, Marco [2 ]
Hanenberg, Helmut [3 ]
Wiek, Constanze [4 ]
Rettie, Allan E. [1 ]
机构
[1] Univ Washington, Sch Pharm, Dept Med Chem, Seattle, WA 98105 USA
[2] Heinrich Heine Univ, Inst Biochem, D-40225 Dusseldorf, Germany
[3] Univ Duisburg Essen, Univ Childrens Hosp Essen, Dept Pediat 3, D-45122 Essen, Germany
[4] Heinrich Heine Univ, Dept Otorhinolaryngol & Head Neck Surg, D-40225 Dusseldorf, Germany
关键词
COVALENT BINDING; RABBIT CYP4B1; IN-VITRO; CYTOCHROME-P450; METABOLITES; CANCER; HEME; P450; CELL; IDENTIFICATION;
D O I
10.1021/acs.chemrestox.9b00330
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cytochrome P450 4B1 (CYP4B1) has been explored as a candidate enzyme in suicide gene systems for its ability to bioactivate the natural product 4-ipomeanol (IPO) to a reactive species that causes cytotoxicity. However, metabolic limitations of IPO necessitate discovery of new "pro-toxicant" substrates for CYP4B1. In the present study, we examined a series of synthetically facile N-alkyl-3-furancarbox-amides for cytotoxicity in HepG2 cells expressing CYP4B1. This compound series maintains the furan warhead of IPO while replacing its alcohol group with alkyl chains of varying length (C1-C8). Compounds with C3-C6 carbon chain lengths showed similar potency to IPO (LD50 approximate to 5 mu M). Short chain analogs (<3 carbons) and long chain analogs (>6 carbons) exhibited reduced toxicity, resulting in a parabolic relationship between alkyl chain length and cytotoxicity. A similar parabolic relationship was observed between alkyl chain length and reactive intermediate formation upon trapping of the putative enedial as a stable pyrrole adduct in incubations with purified recombinant rabbit CYP4B1 and common physiological nucleophiles. These parabolic relationships reflect the lower affinity of shorter chain compounds for CYP4B1 and increased omega-hydroxylation of the longer chain compounds by the enzyme. Furthermore, modest time-dependent inhibition of CYP4B1 by N-pentyl-3-furancarboxamide was completely abolished when trapping agents were added, demonstrating escape of reactive intermediates from the enzyme after bioactivation. An insulated CYP4B1 active site may explain the rarely observed direct correlation between adduct formation and cell toxicity reported here.
引用
收藏
页码:2488 / 2498
页数:11
相关论文
共 50 条
  • [41] Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one Scaffold (vol 63, pg 7817, 2020)
    Ferguson, Fleur M.
    Liu, Yan
    Harshbarger, Wayne
    Huang, Ling
    Wang, Jinhua
    Deng, Xianming
    Capuzzi, Stephen J.
    Muratov, Eugene N.
    Tropsha, Alexander
    Muthuswamy, Senthil
    Westover, Kenneth D.
    Gray, Nathanael S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (17) : 10088 - 10088
  • [42] Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents
    Guo, Rui-Hua
    Zhang, Quan
    Ma, Yun-Bao
    Luo, Jie
    Geng, Chang-An
    Wang, Li-Jun
    Zhang, Xue-Mei
    Zhou, Jun
    Jiang, Zhi-Yong
    Chen, Ji-Jun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (01) : 307 - 319
  • [43] Structure-activity relationships within the N-terminal short consensus repeats (SCR) of human CR1 (C3b/C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation
    Mossakowska, D
    Dodd, I
    Pindar, W
    Smith, RAG
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (06) : 1955 - 1965
  • [44] Synthesis and Structure-Activity Relationships of Aza- and Diazabiphenyl Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
    Kmentova, Iveta
    Sutherland, Hamish S.
    Palmer, Brian D.
    Blaser, Adrian
    Franzblau, Scott G.
    Wan, Baojie
    Wang, Yuehong
    Ma, Zhenkun
    Denny, William A.
    Thompson, Andrew M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (23) : 8421 - 8439
  • [45] Synthesis and Structure-Activity Relationships for Extended Side Chain Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-midazo[2,1-b][1,3]oxazine (PA-824)
    Palmer, Brian D.
    Sutherland, Hamish S.
    Blaser, Adrian
    Kmentova, Ineta
    Franzblau, Scott G.
    Wan, Baojie
    Wang, Yuehong
    Ma, Zhenkun
    Denny, William A.
    Thompson, Andrew M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (07) : 3036 - 3059
  • [46] Synthesis and Structure-Activity Relationships of Varied Ether Linker Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
    Thompson, Andrew M.
    Sutherland, Hamish S.
    Palmer, Brian D.
    Kmentova, Iveta
    Blaser, Adrian
    Franzblau, Scott G.
    Wan, Baojie
    Wang, Yuehong
    Ma, Zhenkun
    Denny, William A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (19) : 6563 - 6585
  • [47] Design, synthesis, and structure-activity relationships of novel 4,7,12,12a-tetrahydro-5H-thieno[3′,2′:3,4]pyrido[1,2-b]isoquinoline and 5,8,12,12a-tetrahydro-6H-thieno[2′,3′: 4,5]pyrido[2,1-a]isoquinoline derivatives as cellular activators of adenosine 5′-monophosphate-activated protein kinase (AMPK)
    Gu, Zhanni
    Wu, Lingyan
    Duan, Yanan
    Wang, Jiang
    Zhou, Shengbin
    Li, Jingya
    Chen, Kaixian
    Li, Jia
    Liu, Hong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (08) : 2017 - 2027
  • [48] Structure-Activity Relationships of Antitubercular Nitroimidazoles. 3. Exploration of the Linker and Lipophilic Tail of ((S)-2-Nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-Amino PA-824).
    Cherian, Joseph
    Choi, Inhee
    Nayyar, Arnit
    Manjunatha, Ujjini H.
    Mukherjee, Tathagata
    Lee, Yong Sok
    Boshoff, Helena I.
    Singh, Ramandeep
    Ha, Young Hwan
    Goodwin, Michael
    Lakshminarayana, Suresh B.
    Niyomrattanakit, Pornwaratt
    Jiricek, Jan
    Rayindran, Sindhu
    Dick, Thomas
    Keller, Thomas H.
    Dartois, Veronique
    Barry, Clifton E., III
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (16) : 5639 - 5659
  • [49] Structure-Activity Relationships for Amide-, Carbamate-, And Urea-Linked Analogues of the Tuberculosis Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
    Blaser, Adrian
    Palmer, Brian D.
    Sutherland, Hamish S.
    Kmentova, Iveta
    Franzblau, Scott G.
    Wan, Baojie
    Wang, Yuehong
    Ma, Zhenkun
    Thompson, Andrew M.
    Denny, William A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) : 312 - 326
  • [50] Structure-activity relationships in 1,4-benzodioxan-related compounds.: 8.: {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of α1D- and α1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation
    Quaglia, W
    Santoni, G
    Pigini, M
    Piergentili, A
    Gentili, F
    Buccioni, A
    Mosca, M
    Lucciarini, R
    Amantini, C
    Nabissi, MI
    Ballarini, P
    Poggesi, E
    Leonardi, A
    Giannella, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) : 7750 - 7763